Clinical Trials Sponsored by The Peanut Institute

Total 5037 results

The Netherlands Cancer Institute

Recruiting

Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VULCANize) (VULCANize)

Locally Advanced, Squamous Cell Carcinoma of the Vulva

Netherlands
The Netherlands Cancer Institute

Recruiting

Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy (CRAVAT)

Metastatic Squamous Cell Carcinoma of the Vulva

Netherlands
The Netherlands Cancer Institute

Recruiting

Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (OVHIPEC-2)

Ovarian Cancer

Netherlands, United States, France, Denmark, Italy, Sweden, Ireland
The Netherlands Cancer Institute

Not yet recruiting

Sentinel Lymph Node Procedure in Testicular Germ Cell Tumour (SENATOR)

Testicular Germ Cell Tumor
The Netherlands Cancer Institute

Completed

ctDNA as a Biomarker for Treatment Response in HNSCC (PECAN)

Carcinoma, Squamous Cell of Head and Neck

Netherlands
The Netherlands Cancer Institute

Completed

ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurrent Head and Neck Carcinoma (IMCISION)

Head and Neck Neoplasms | Immunotherapy

Netherlands
The Netherlands Cancer Institute

Completed

CYP3A4 Activity in Patients With Prostate Cancer Versus Male Patients With Other Solid Tumours

Prostate Cancer | Solid Tumor, Adult

Netherlands
The Netherlands Cancer Institute

Completed

Diagnostic Yield of Colonoscopy Surveillance in Testicular Cancer Survivors Treated With Platinum-based Chemotherapy (CATCHER)

Colorectal Neoplasms | Testicular Cancer

Netherlands
The Netherlands Cancer Institute

Completed

INtra-operative Evaluation of a Novel FLUorescENt C-mEt Tracer in Penile and Tongue (INFLUENCE)

Head and Neck Cancer | Penile Cancer

Netherlands
The Netherlands Cancer Institute

Active, not recruiting

High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer (Oligo)

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel (OSTRICh)

Metastasis | Prostate Cancer Metastatic

Netherlands
The Netherlands Cancer Institute

Unknown

Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric Cancer (B-DOCT)

Metastatic Gastric Cancer | Adenocarcinoma of the Gastro-oesophageal Junction

Netherlands
The Netherlands Cancer Institute

Unknown

Technetium Based Radioguided Surgery for Prostate Cancer (TRACE) Study (TRACE)

Prostate Cancer

Netherlands
The Netherlands Cancer Institute

Terminated

Comparing Two Palliative Schemes of Radiotherapy for Head and Neck Cancer (COOPERATION)

Head and Neck Neoplasms

Netherlands
The Netherlands Cancer Institute

Completed

Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously (VOLUMES)

Lung Cancer | Metastatic Lung Cancer

Netherlands, United States, Canada, Germany
The Netherlands Cancer Institute

Completed

Organ Motion and Early Tumor Response Measurement

Esophageal Cancer | Chemoradiation

Netherlands
The Netherlands Cancer Institute

Completed

Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer (REVIVAL)

Breast Cancer | Ovarian Cancer | Advanced Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Weekly Administration of (bi-)Daily Oral Docetaxel in Combination With Ritonavir

Cancer

Netherlands
The Aurum Institute NPC

Unknown

TB Host Directed Therapy (TBHDT)

Tuberculosis

South Africa
The Netherlands Cancer Institute

Unknown

Study With T-cel Receptor Gene Therapy in Metastatic Melanoma (TCR)

Stage IV Skin Melanoma | Eye; Melanoma

Netherlands
The Netherlands Cancer Institute

Completed

Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer

Ovarian Cancer

Netherlands
The Netherlands Cancer Institute

Unknown

Clinical Impact of Dedicated MR Staging of Ovarian Cancer (MRStagingOC)

Ovarian Cancer

Netherlands
The Netherlands Cancer Institute

Completed

4D FDG PET in Esophageal Cancer

Esophageal Cancer

Netherlands
The Netherlands Cancer Institute

Completed

The Development of a Personalized Decision Aid: Perspectives of Patients and Health Care Professionals on Shared Decision Making and Informational Needs on Radiotherapy for Breast Cancer (M16SDM)

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Unknown

Food-effect Study on Uracil and Dihydrouracil Levels as a Diagnostic Marker of Dihydropyrimidine Dehydrogenase Activity

Drug Safety Biomarkers

Netherlands
The Netherlands Cancer Institute

Completed

Dexamphetamine Sustained Release Pharmacokinetics and Clinical Validation of Dried Blood Spots

Cocaine Addiction

Netherlands
The Netherlands Cancer Institute

Unknown

Prospective Pilot Study ANDPrecise (ANDPrecise)

Breast Cancer

Netherlands
The George Institute
Servier

Completed

Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study (ADVANCE-ON)

Diabetes Mellitus, Type 2

Australia, Canada, China, Czech Republic, Estonia, France, Germany, Hungary, India, Ireland, Italy, Lithuania, Malaysia, Netherlands, New Zealand, Philippines, Poland, Russian Federation, Slovakia, United Kingdom
The Cooper Institute
Cargill

Completed

Phytosterol Supplementation and Cardiovascular Risk

Hypercholesteremia

United States
The Netherlands Cancer Institute

Unknown

Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases

Meningeal Carcinomatosis

Netherlands
The George Institute
Heart Research Institute

Recruiting

Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke (STARS)

Acute Ischemic Stroke

Australia
Karolinska Institutet
The George Institute for Global Health, India

Not yet recruiting

ATLS vs Standard Care Trial

Wounds and Injuries
The Methodist Hospital Research Institute

Recruiting

IL-2 Plus Abatacept in FTD

Frontotemporal Degeneration

United States
The Methodist Hospital Research Institute

Recruiting

Systemic and Central Inflammation in AD

Alzheimer Disease

United States
The Methodist Hospital Research Institute

Recruiting

CBD for Pain Following Orthopedic Shoulder Surgery (CBD)

Rotator Cuff Injuries | Shoulder Osteoarthritis

United States
The Methodist Hospital Research Institute

Recruiting

Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity

Obesity | Endoscopic Sleeve Gastroplasty

United States
The Methodist Hospital Research Institute

Not yet recruiting

Home Tele Rehabilitation Therapy for Vascular Dementia

Dementia, Vascular | Stroke Sequelae
The Methodist Hospital Research Institute

Not yet recruiting

Personalized Transcranial Direct Current Stimulation in Stroke Recovery

Stroke
The Methodist Hospital Research Institute

Not yet recruiting

Augmenting Rehabilitation Outcomes and Functional Neuroplasticity Using Epidural Stimulation of Cervical Spinal Cord

Spinal Cord Injuries | Cervical Spinal Cord Injury
The Methodist Hospital Research Institute

Recruiting

ORIF Distal Radius Blood Flow Restriction Therapy (ORIF DR BFR)

Distal Radius Fractures

United States
The Methodist Hospital Research Institute

Recruiting

Phase II Clinical Trial of Interleukin-2 in AD

Alzheimer Disease

United States
The Bionics Institute of Australia

Recruiting

Improving Early Intervention in Hearing Impaired Children Using Functional Near-Infrared Spectroscopy (fNIRS)

Hearing Impairment

Australia
The Methodist Hospital Research Institute

Recruiting

IO Vancomycin in TSA

Shoulder Injuries

United States
The Methodist Hospital Research Institute

Recruiting

Venous Ethanol for Ventricular Tachycardia (VELVET)

Ventricular Tachycardia | Ischemic Cardiomyopathy

United States
The Methodist Hospital Research Institute

Recruiting

HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

Prostatic Neoplasms

United States
The Methodist Hospital Research Institute

Enrolling by invitation

Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

Kidney Failure, Chronic | Kidney Transplant Rejection | Graft Rejection | Kidney Transplant; Complications | Kidney Transplant Failure | Kidney Transplant Failure and Rejection | Interstitial Fibrosis

United States
The Methodist Hospital Research Institute

Completed

Brain Imaging in Men With Lower Urinary Tract Symptoms

Voiding Disorders

United States
The Netherlands Cancer Institute
Bayer

Completed

Registry of Treatment Outcomes of Symptomatic Metastasized Castration Resistant Prostate Cancer Treated With Radium-223 (ROTOR)

Bone Metastases | Prostate Cancer Metastatic

Netherlands
The Netherlands Cancer Institute
AstraZeneca

Suspended

Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer

Breast Cancer

Netherlands
The Methodist Hospital Research Institute

Completed

Effects of Blood Flow Restriction Rehabilitation After Anterior Cruciate Ligament Reconstruction

ACL Tear

Clinical Trials Sponsored by The Peanut Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations